1. Home
  2. ROIV

ROIV

Roivant Sciences Ltd.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Roivant Sciences Ltd is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients.

Founded: 2014 Country:
United Kingdom
United Kingdom
Employees: N/A City: HAMILTON HM11
Market Cap: 9.0B IPO Year: N/A
Target Price: $16.90 AVG Volume (30 days): 7.4M
Analyst Decision: Strong Buy Number of Analysts: 10
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 5.22 EPS Growth: N/A
52 Week Low/High: $7.01 - $13.24 Next Earning Date: 02-13-2024
Revenue: $123,241,000 Revenue Growth: 185.76%
Revenue Growth (this year): 138.71% Revenue Growth (next year): 22.33%

Share on Social Networks: